United States (US) Tumor Profiling Market (2025-2031) | Outlook, Value, Competitive Landscape, Trends, Growth, Size & Revenue, Forecast, Companies, Segmentation, Share, Industry, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Tumor Profiling Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Tumor Profiling Market - Industry Life Cycle

3.4 United States (US) Tumor Profiling Market - Porter's Five Forces

3.5 United States (US) Tumor Profiling Market Revenues & Volume Share, By Technique, 2021 & 2031F

3.6 United States (US) Tumor Profiling Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.7 United States (US) Tumor Profiling Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in the United States

4.2.2 Technological advancements in tumor profiling techniques

4.2.3 Rising demand for personalized medicine and targeted therapies

4.2.4 Growing investments in healthcare infrastructure and research

4.2.5 Supportive government initiatives and funding for cancer research

4.3 Market Restraints

4.3.1 High cost associated with tumor profiling tests

4.3.2 Limited awareness and accessibility in certain regions

4.3.3 Regulatory challenges and compliance requirements

4.3.4 Data privacy and security concerns related to genetic information

4.3.5 Lack of skilled professionals for complex tumor profiling procedures

6.1 United States (US) Tumor Profiling Market, By Technique

6.1.1 Overview and Analysis

6.1.2 United States (US) Tumor Profiling Market Revenues & Volume, By Technique, 2021- 2031F

6.1.3 United States (US) Tumor Profiling Market Revenues & Volume, By Genomics, 2021- 2031F

6.1.4 United States (US) Tumor Profiling Market Revenues & Volume, By Proteomics, 2021- 2031F

6.1.5 United States (US) Tumor Profiling Market Revenues & Volume, By Metabolomics, 2021- 2031F

6.1.6 United States (US) Tumor Profiling Market Revenues & Volume, By Epigenetics, 2021- 2031F

6.2 United States (US) Tumor Profiling Market, By Technology

6.2.1 Overview and Analysis

6.2.2 United States (US) Tumor Profiling Market Revenues & Volume, By Sequencing Techniques, 2021- 2031F

6.2.3 United States (US) Tumor Profiling Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F

6.2.4 United States (US) Tumor Profiling Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F

6.2.5 United States (US) Tumor Profiling Market Revenues & Volume, By qPCR, 2021- 2031F

6.2.6 United States (US) Tumor Profiling Market Revenues & Volume, By Microarray, 2021- 2031F

6.3 United States (US) Tumor Profiling Market, By Application

6.3.1 Overview and Analysis

6.3.2 United States (US) Tumor Profiling Market Revenues & Volume, By Personalized Medicine, 2021- 2031F

6.3.3 United States (US) Tumor Profiling Market Revenues & Volume, By Oncological Diagnostics, 2021- 2031F

6.3.4 United States (US) Tumor Profiling Market Revenues & Volume, By Research, 2021- 2031F

7.1 United States (US) Tumor Profiling Market Export to Major Countries

7.2 United States (US) Tumor Profiling Market Imports from Major Countries

8.1 Adoption rate of tumor profiling technologies in clinical settings

8.2 Number of research studies and publications utilizing tumor profiling data

8.3 Rate of integration of tumor profiling results into treatment decision-making

8.4 Patient outcomes and survival rates following personalized treatments based on tumor profiles

8.5 Number of partnerships and collaborations between healthcare providers and technology companies in the tumor profiling sector

9.1 United States (US) Tumor Profiling Market Opportunity Assessment, By Technique, 2021 & 2031F

9.2 United States (US) Tumor Profiling Market Opportunity Assessment, By Technology, 2021 & 2031F

9.3 United States (US) Tumor Profiling Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 United States (US) Tumor Profiling Market Revenue Share, By Companies, 2024

10.2 United States (US) Tumor Profiling Market Competitive Benchmarking, By Operating and Technical Parameters